Basic Information
| RNALocate ID: | RLID-D:11001766 |
| RNA Symbol: | hsa-miR-1915-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-1915-3p |
| RNA ID: | miRBase:MIMAT0007892 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
| Database: | EVmiRNA |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11004412 | Exosome | Pooled sera | 27278097 |
| RLID:11004413 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11004414 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11004415 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11004211 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-1915-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-22485 |
| MNDR | hsa-miR-1915-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-22486 |
| MNDR | hsa-miR-1915-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-22487 |
| MNDR | hsa-miR-1915-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-22488 |
| MNDR | hsa-miR-1915-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-22489 |
| MNDR | hsa-miR-1915-3p | Colorectal carcinoma | MNDR-E-MI-22490 |
| MNDR | hsa-miR-1915-3p | Gastric cancer | MNDR-E-MI-22491 |
| MNDR | hsa-miR-1915-3p | Intracranial aneurysm | MNDR-E-MI-22492 |
| MNDR | hsa-miR-1915-3p | Focal segmental glomerulosclerosis | MNDR-E-MI-22493 |
| MNDR | hsa-miR-1915-3p | Parkinson disease | MNDR-E-MI-22494 |
| MNDR | hsa-miR-1915-3p | Breast cancer | MNDR-E-MI-22495 |
| MNDR | hsa-miR-1915-3p | Pancreatic cancer | MNDR-E-MI-22496 |
| MNDR | hsa-miR-1915-3p | Nephroblastoma | MNDR-E-MI-22497 |
| MNDR | hsa-miR-1915-3p | Colon cancer | MNDR-E-MI-22498 |
| MNDR | hsa-miR-1915-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-22499 |
| MNDR | hsa-miR-1915-3p | Ovarian cancer | MNDR-E-MI-22500 |
| MNDR | hsa-miR-1915-3p | Invasive ductal carcinoma | MNDR-E-MI-22501 |
| MNDR | hsa-miR-1915-3p | Glioblastoma | MNDR-E-MI-22502 |
| MNDR | hsa-miR-1915-3p | Chordoma | MNDR-E-MI-22503 |
| MNDR | hsa-miR-1915-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-22504 |
| MNDR | hsa-miR-1915-3p | Meningioma | MNDR-E-MI-22505 |
| MNDR | hsa-miR-1915-3p | Liver cancer | MNDR-E-MI-22506 |
| MNDR | hsa-miR-1915-3p | Lung adenocarcinoma | MNDR-E-MI-22507 |
| MNDR | hsa-miR-1915-3p | Biliary tract cancer | MNDR-E-MI-22508 |
| MNDR | hsa-miR-1915-3p | Cholangiocarcinoma | MNDR-E-MI-22509 |
| MNDR | hsa-miR-1915-3p | Esophageal cancer | MNDR-E-MI-22510 |
| MNDR | hsa-miR-1915-3p | Lung small cell carcinoma | MNDR-E-MI-22511 |
| MNDR | hsa-miR-1915-3p | Progressive supranuclear palsy | MNDR-E-MI-22512 |
| MNDR | hsa-miR-1915-3p | Hepatocellular carcinoma | MNDR-E-MI-22513 |
| MNDR | hsa-miR-1915-3p | Hodgkin lymphoma | MNDR-E-MI-22514 |
| MNDR | hsa-miR-1915-3p | Colorectal cancer | MNDR-E-MI-22515 |
| MNDR | hsa-miR-1915-3p | Nasopharynx carcinoma | MNDR-E-MI-22516 |
| MNDR | hsa-miR-1915-3p | Nasopharyngeal cancer | MNDR-E-MI-22517 |
| MNDR | hsa-miR-1915-3p | Stroke lacunar | MNDR-E-MI-22518 |
| MNDR | hsa-miR-1915-3p | Breast cancer her3+ negative | MNDR-E-MI-22519 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | BCL2 | Homo sapiens | RR00219014 |
TOP